• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZOLL CIRCULATION AUTOPULSE® RESUSCITATION MODEL 100; CARDIAC CHEST COMPRESSOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZOLL CIRCULATION AUTOPULSE® RESUSCITATION MODEL 100; CARDIAC CHEST COMPRESSOR Back to Search Results
Model Number MODEL 100
Device Problem Use of Device Problem (1670)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 02/09/2019
Event Type  malfunction  
Manufacturer Narrative
The customer reported complaint for the platform stopped compressions was confirmed during archive data review but not during the functional testing.Visual inspection was performed and found no physical damage to the autopulse platform.The autopulse passed the initial functional test without any fault or error.Review of the archive data indicated error message user advisory (ua) 07 on the customer reported event date, thus confirming the reported complaint.The load cell characterization test confirmed the load cell module is defective and the replacement is required to address the reported issue.Upon customer approval, the components will be replaced and the device will be further tested to full specification.Historical complaints were reviewed for service information related to the reported complaint and there was no previous history of complaints for autopulse platform sn (b)(4).The death was not related to the autopulse device.The autopulse is used as an adjunct to manual cpr in cases of clinical death.The benefit of using the autopulse is that it in part substitutes mechanical compressions for the physical labor of manual chest compressions.If the autopulse did not start or unexpectedly stops compressions, rescuer should revert to manual cpr, which is the standard of care.In this case, when the autopulse platform (sn (b)(4)) was used on a cardiac arrest patient, it stopped after the first compression.Manual cpr was performed when the use of the autopulse platform was discontinued.A return of spontaneous circulation (rosc) was not achieved and the patient expired.The autopulse was intended to be used as an adjunct to manual cpr on adult patients.In case of stoppage of autopulse the user reverts to manual cpr.The transition from autopulse to manual cpr by trained users is similar to the time necessary for rescuer rotation, and presents the same workflow as manual cpr.Hence, based on available information, the patients' outcome was not negatively impacted by the interruptions when compared to standard of care manual cpr.Out-of-hospital cardiac arrest (ohca) is one of the main causes of death in industrial nations.About 25% of patients survive this event and make it to the hospital, and even fewer patients survive after 24 hours (nichol, nejm, 2015).In the united states, survival to hospital discharge after non-traumatic emergency medical services-treated cardiac arrest with any first recorded rhythm was 10.6% for patients of any age.Of the bystander-witnessed out-of-hospital cardiac arrests in 2011, 31.4% of victims survived to hospital discharge (mozaffarian, circulation, 2016).Death is an expected outcome for ohca.
 
Event Description
During the call, the autopulse platform (sn (b)(4)) was used on an (b)(6) male patient ((b)(6)) in cardiac arrest.The cardiac arrest was witnessed.Per the reporter, the patient had an extensive medical history.The platform stopped after the first compression.No error messages were displayed on the platform lcd screen.Troubleshooting steps were performed without any success.The use of the autopulse platform was discontinued and manual cpr was performed.A return of spontaneous circulation (rosc) was not achieved, the patient was in asystole through the entire event and never presented a shockable rhythm.Cause of death is unknown.According to the reporter, the patient's death was not related to the delay caused by the device issue.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AUTOPULSE® RESUSCITATION MODEL 100
Type of Device
CARDIAC CHEST COMPRESSOR
Manufacturer (Section D)
ZOLL CIRCULATION
2000 ringwood ave.
san jose CA 95131
Manufacturer (Section G)
ZOLL CIRCULATION
2000 ringwood ave.
san jose CA 95131
Manufacturer Contact
noemi schambach
2000 ringwood ave,
san jose, CA 95131
4084192955
MDR Report Key8392889
MDR Text Key138087826
Report Number3010617000-2019-00176
Device Sequence Number1
Product Code DRM
UDI-Device Identifier00849111000512
UDI-Public00849111000512
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K112998
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 03/05/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/05/2019
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberMODEL 100
Device Catalogue Number8700-0730-01
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/21/2019
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/12/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/08/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Age83 YR
Patient Weight91
-
-